Jennifer B. Damico - 25 Feb 2026 Form 4 Insider Report for PFIZER INC (PFE)

Signature
/s/ Shanice A. Reid, by power of atty, for Jennifer B. Damico
Issuer symbol
PFE
Transactions as of
25 Feb 2026
Net transactions value
+$134,818
Form type
4
Filing time
27 Feb 2026, 18:35:07 UTC
Previous filing
24 Feb 2026
Next filing
03 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DAMICO JENNIFER B. SVP & Controller 66 HUDSON BOULEVARD EAST, ATTN: CORPORATE SECRETARY, NEW YORK /s/ Shanice A. Reid, by power of atty, for Jennifer B. Damico 27 Feb 2026 0001805617

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Options Exercise $593,812 +17,558 +144% $33.82 29,744 25 Feb 2026 Direct F1
transaction PFE Common Stock Tax liability $9,779 -361 -1.2% $27.09 29,383 25 Feb 2026 Direct F2
transaction PFE Common Stock Tax liability $449,214 -16,687 -57% $26.92 12,696 25 Feb 2026 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Options Exercise $0 -17,558 -100% $0.000000 0 25 Feb 2026 Common Stock 17,558 $33.82 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.